Overview of the Drug
The drug with the National Drug Code (NDC) 51801-007 is Effer-K 25 mEq, which are Potassium Bicarbonate Effervescent Tablets for Oral Solution, USP. These tablets are designed to prepare an oral solution of potassium, making them a crucial supplement for individuals with potassium deficiencies or those requiring potassium supplementation[1].
Market Context
Current Market Trends
The pharmaceutical market is experiencing significant changes, including price inflation and shifts in demand. According to Vizient, Inc., the overall drug price inflation rate for pharmaceuticals in 2025 is projected to be 3.81%. This inflation is partly driven by the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[3].
Seasonal Price Increases
Historically, most prescription drug price increases occur in January and July. In January 2022, for example, over 3000 drugs experienced a price increase, with an average increase of nearly $150 per drug (10 percent). July increases tend to be for higher-priced drugs, resulting in higher dollar increases but smaller percentage increases[5].
Pricing Analysis
Current Pricing
The pricing for Effer-K 25 mEq tablets can vary based on the package size and flavor. For instance, the unflavored version (NDC 51801-007) comes in a package of 30 tablets. However, specific current pricing data for this NDC is not readily available in the provided sources.
Price Projections
Given the general trend of drug price inflation, it is reasonable to expect that the price of Effer-K 25 mEq tablets will increase. Here are some key points to consider:
- General Inflation: With an overall drug price inflation rate projected at 3.81% for 2025, Effer-K 25 mEq tablets are likely to see a similar or slightly lower increase, depending on market conditions and competition[3].
- Seasonal Adjustments: Prices may adjust more significantly in January and July, following the industry's typical pricing patterns[5].
Significant Price Increases
While not all price changes are significant, drugs that experience substantial price changes (greater than $20 per package or a 10 percent change within a 12-month period) are noteworthy. For Effer-K, any significant price increase would likely be driven by broader market trends rather than specific product demand, as it is a relatively stable supplement product[5].
Market Factors Influencing Pricing
Demand and Supply
The demand for potassium supplements like Effer-K can be influenced by various factors, including dietary trends, health awareness, and the prevalence of conditions requiring potassium supplementation. Supply chain disruptions or changes in raw material costs can also impact pricing.
Regulatory Environment
Regulatory changes and updates can affect the pricing of pharmaceuticals. For instance, changes in FDA regulations or reimbursement policies can influence the overall cost structure of the drug[4].
Competitive Landscape
The competitive landscape for potassium supplements is relatively stable, with several brands offering similar products. This competition can help keep price increases in check, as manufacturers aim to remain competitive in the market.
Consumer and Provider Impact
Patient Affordability
Price increases can significantly impact patient affordability, especially for those relying on long-term supplementation. Even moderate price increases can add up over time, making it essential for patients to monitor pricing changes and explore any available discounts or alternative products.
Provider Budgets
Healthcare providers and pharmacies need to prepare for price increases by adjusting their budgets and operational processes. This includes negotiating better prices with suppliers and managing inventory to minimize the impact of price fluctuations[3].
Key Takeaways
- Price Inflation: Expect a general price inflation of around 3.81% for pharmaceuticals in 2025.
- Seasonal Adjustments: Prices are likely to adjust more significantly in January and July.
- Market Trends: Broader market trends, including demand and supply dynamics, regulatory changes, and competitive pressures, will influence the pricing of Effer-K 25 mEq tablets.
- Patient and Provider Impact: Price increases can affect patient affordability and provider budgets, necessitating careful management and planning.
FAQs
What is the NDC for Effer-K 25 mEq unflavored tablets?
The NDC for Effer-K 25 mEq unflavored tablets is 51801-007[1].
How often do prescription drug prices typically increase?
Prescription drug prices typically increase in January and July, with the majority of increases occurring in January[5].
What is the projected drug price inflation rate for 2025?
The projected overall drug price inflation rate for pharmaceuticals in 2025 is 3.81% according to Vizient, Inc.[3].
How do seasonal price increases affect higher-priced drugs?
Seasonal price increases in July tend to be for higher-priced drugs, resulting in higher dollar increases but smaller percentage increases compared to January increases[5].
What factors influence the pricing of Effer-K 25 mEq tablets?
The pricing of Effer-K 25 mEq tablets is influenced by general market trends, demand and supply dynamics, regulatory changes, and the competitive landscape[3][5].
Sources
- DailyMed: Potassium Bicarbonate Tablet, Effervescent EFFER-K CHERRY BERRY.
- DrugPatentWatch: Latest drug prices and trends for NDC 51672-1387.
- Vizient Inc.: Vizient projects drug price inflation at 3.81%.
- FDA: NDC Directory (March 2015).
- ASPE: Price Increases for Prescription Drugs, 2016-2022.
